Fulgent Genetics (FLGT) Non-Current Assets (2015 - 2026)

Fulgent Genetics has disclosed Non-Current Assets across 12 years of filings, most recently posting $677.3 million for Q1 2026.

• Non-Current Assets for Q1 2026 came in at $677.3 million, down 14.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.8 billion (down 16.99% YoY), and the FY2025 annual result was $663.0 million, down 23.47% from the prior year.
• Non-Current Assets came in at $677.3 million for Q1 2026 at Fulgent Genetics, up from $663.0 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $907.2 million in Q3 2024 to a low of -$534.6 million in Q4 2022.
• The 5-year median for Non-Current Assets is $786.5 million (2022), against an average of $698.7 million.
• Across the five-year window, Non-Current Assets tumbled 180.18% in 2022 and surged 236.07% in 2023, its largest moves.
• Fulgent Genetics' Non-Current Assets stood at -$534.6 million in 2022, then soared by 236.07% to $727.5 million in 2023, then grew by 19.09% to $866.4 million in 2024, then fell by 23.47% to $663.0 million in 2025, then climbed by 2.16% to $677.3 million in 2026.
• The last three Non-Current Assets figures came in at $677.3 million (Q1 2026), $663.0 million (Q4 2025), and $707.2 million (Q3 2025), per Business Quant data.